InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,987.57
(
-0.47%
)
US TECH 100
16,665.85
(
-1.60%
)
Dow Jones
37,995.38
(
0.58%
)
Brent Oil
86.97
(
0.64%
)
Bitcoin
64,234.32
(
1.14%
)
Post# of 2543
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Ultimate Warrior

Send PM Follow Ignore
Followers 54
Posts 4488
Boards Moderated 0
Alias Born 04/18/2009

Ultimate Warrior

Re: None

Thursday, 09/15/2016 3:15:16 PM

Thursday, September 15, 2016 3:15:16 PM

Post# of 2543
Another puzzle piece? This story from earlier this year might provide insight into the reason Venn is seeking a presence in US markets.

http://www.irishtimes.com/business/health-pharma/dublin-based-venn-life-sciences-wins-dual-listing-approval-1.2500775

"Venn, a provider of clinical trial management services to pharmaceutical, biotech and medical device companies, said last week it had signed new contracts worth over €3.4 million with a leading unnamed US-based biotechnology client."
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up